Delta-8 and Derivative Cannabinoid Products Reshape Cannabis Revenue Mix
By Sheeba M. | May 6, 2026 Delta-8 and Derivative Cannabinoid Products Reshape Cannabis Revenue Mix TL;DR: Federally legal derivative cannabinoids now represent 18% of cannabis retailer revenue nationally, forcing MSOs to pivot product strategy and creating new valuation challenges for legacy flower-focused operators. The cannabis revenue mix is fracturing. What was once a simple […]
Cannabis MSOs Post Record Profitability as Federal Headwinds Ease
By Sheeba M. | May 6, 2026 Cannabis MSOs Post Record Profitability as Federal Headwinds Ease TL;DR: Multi-state operators report Q1 2026 EBITDA margins above 25% for the first time, signaling a pivotal shift toward sustainable profitability as banking reform gains momentum. The cannabis sector is experiencing a watershed moment. Major multi-state operators (MSOs) including […]
Cannabis Tax Deduction Debate Heats Up in Congress
By Sheeba M. | May 5, 2026 Cannabis Tax Deduction Debate Heats Up in Congress TL;DR: New bipartisan bill seeks to repeal Section 280E, allowing cannabis operators to deduct standard business expenses. If passed, could improve profitability for publicly traded companies by 15-20%. Cannabis industry stakeholders are watching Congress closely this week as a new […]
Hemp Delta-9 Faces Federal Crackdown: Which Cannabis Operators Win?
By Sheeba M. | May 4, 2026 Hemp Delta-9 Faces Federal Crackdown: Which Cannabis Operators Win? TL;DR: The FDA is moving to regulate hemp-derived Delta-9 products by November 2026. This kills the $2B+ unregulated hemp THC market but hands MSOs like CURLF and GTBIF a licensing monopoly. Operators with established regulated channels see a 3-5 […]
Cannabis Debt Markets Thaw as Institutional Capital Returns
By Sheeba M. | May 4, 2026 Cannabis Debt Markets Thaw as Institutional Capital Returns TL;DR: With federal rescheduling moving to Schedule III, banks are lifting lending restrictions on MSOs. Debt capital markets are opening up with 6-8% rates instead of 12%+, creating a refinancing bonanza for operators like CURLF and GTBIF. Early movers can […]
Schedule III Rescheduling: Why Bank Access Could Be the Real Game-Changer for Cannabis MSOs
By Sheeba M. | May 4, 2026 Schedule III Rescheduling: Why Bank Access Could Be the Real Game-Changer for Cannabis MSOs TL;DR: As cannabis moves closer to Schedule III status, traditional banking access becomes unlocked—potentially saving MSOs $500M+ annually in working capital costs. This structural change could drive a 20-30% EPS uplift for the largest […]
Cannabis Beverage Market Set to Double: Which Companies Are Positioned to Win?
By Sheeba M. | May 4, 2026 Cannabis Beverage Market Set to Double: Which Companies Are Positioned to Win? TL;DR: Industry analysts project cannabis beverages will reach $14.4B by 2028 as consumer preference shifts toward infused drinks. Major players like Tilray and Cronos are scaling production, signaling strong margin expansion ahead. The cannabis beverage category […]
Consolidation Wave Accelerates: Why 2026 Could Be the Year of MSO Mega-Deals
By Sheeba M. | May 04, 2026 Consolidation Wave Accelerates: Why 2026 Could Be the Year of MSO Mega-Deals TL;DR: Falling valuations and rising debt loads are forcing smaller MSOs to the negotiating table, signaling a consolidation wave that could reshape the industry before rescheduling closes the M&A window. The cannabis M&A pipeline is heating […]
Cannabis MSOs Eye Federal Rescheduling as Tax Reform Opportunity Looms
By Sheeba M. | May 04, 2026 Cannabis MSOs Eye Federal Rescheduling as Tax Reform Opportunity Looms TL;DR: As federal rescheduling moves closer, major cannabis operators like Curaleaf and Greenrose are positioning for significant tax reform, potentially unlocking billions in deductions currently blocked under 280E. The cannabis industry is at an inflection point. After years […]
From the Village Green – May 4, 2026
Curated from social media posts and threads